The past 18 months have been absolutely terrible for Novo Nordisk (NYSE: NVO). The Denmark-based drugmaker has faced poor ...
Look to the Fed to help stocks climb higher in 2026, says Fundstrat's Tom Lee. - . Thursday could be telling in whether ...